The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Strong Historical Growth

• Market Size: Grew from $3.14 billion in 2023 to $3.35 billion in 2024.
• CAGR: 6.7%.
• Key Drivers:
  • Growth in medical tourism.
  • Increasing need for aortic aneurysm management.
  • Rising number of aortic aneurysm cases.
  • Technical success of endograft implantation.
  • Increase in the number of hospitals.

Promising Future Outlook

• Expected Growth: Projected to reach $4.08 billion by 2028.
• CAGR: 5.1%.
• Key Drivers:
  • Increasing prevalence of abdominal aortic aneurysm.
  • Growing preference for minimally invasive procedures.
  • Rising geriatric population.
  • Advancements in stent-graft materials and configurations.
  • Introduction of new stent-graft products.

Read More On The Aortic Endograft Market Report 2024 – https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

Market Trends and Innovations

• Trends:
  • Adoption of endovascular abdominal aortic aneurysm (AAA) repair devices.
  • Effectiveness of unibody and non-unibody aortic stents.
  • Product innovation.

Rising Incidence of Aortic Aneurysms

• Aortic Aneurysms: Localized dilation or bulging of the aorta.
• Treatment: Aortic endografts are less invasive than traditional surgery, involving a fabric-covered metal or polymer device inserted via a catheter.
• Screening Statistics: In the UK, 274,800 men were screened between April 2021 and March 2022, identifying 1,794 aneurysms.

Key Players in the Market

• Major Companies:
  • Cardinal Health Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • Becton, Dickinson and Company
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Terumo Corporation
  • W. L. Gore & Associates Inc.
  • Cook Medical Inc.
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • LifeTech Scientific Corporation
  • Altura Medical Inc.
  • MicroVention Inc.
  • MicroPort Scientific Corporation
  • CryoLife Inc.
  • Cordis Corporation
  • Endologix LLC

Innovations in Medical Devices

• Castor-Branched Aortic Stent Graft System:
  • Manufacturer: Shanghai MicroPort Endovascular MedTech Group Co. Ltd.
  • Launch: December 2021.
  • Features: Minimally invasive repair of aorta and aortic arch, especially in Stanford type B aortic dissection (TBAD). Unique unibody design conforming to diverse arch anatomies, offering one-time access and release, and promoting long-term stability.

Strategic Acquisitions

• Endologix LLC: Acquired PQ Bypass Inc. in April 2021.
  • Objective: Expand and reinforce its position in abdominal aortic aneurysm treatment.
  • PQ Bypass Inc.: US-based medical device company specializing in aortic endografts.

Market Segmentation

• By Product:
  • Abdominal Aortic Grafts.
  • Thoracic Aortic Grafts.
• By Material:
  • Metallic Endografts.
  • Polymeric Endografts.
• By Procedure:
  • Open Surgical Repair.
  • Endovascular Aneurysm Repair (EVAR).
• By End User:
  • Hospitals.
  • Ambulatory Surgical Centers.

Regional Insights

• Largest Region (2023): North America.
• Fastest-Growing Region (Forecast Period): Asia-Pacific.

Request for A Sample Of The Global Aortic Endograft Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13784&type=smp